Article
Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci.
Journal of chemotherapy (Florence, Italy) - 1 Dec 2020
Ibrahim Yasser Musa, Abu El-Wafa Wael Mohamed
Abstract excerpt
The pathogenic potential of coagulase-negative staphylococci (CoNS) is increasingly recognized worldwide. The aim of the present study was to evaluate different combinations of fosfomycin (FOS) with vancomycin (VAN) or oxacillin (OXA) against vancomycin-resistant clinical isolates of CoNS. Characterization of VAN resistance in selected isolates was also sought. Antibiotic susceptibility of isolates was tested by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
